---
annotation-target: s41586-022-05019-y.pdf
---


>%%
>```annotation-json
>{"created":"2022-08-30T03:43:34.204Z","text":"泰斯巴汀，是美国科学家发现的近30年来第一种新型抗生素，其可以杀死耐甲氧西林金黄色葡萄球菌(MRSA)等多种致命病原体。","updated":"2022-08-30T03:43:34.204Z","document":{"title":"Teixobactin kills bacteria by a two-pronged attack on the cell envelope","link":[{"href":"urn:x-pdf:ca6519d0e48a08449bcc274124342edf"},{"href":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf"}],"documentFingerprint":"ca6519d0e48a08449bcc274124342edf"},"uri":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","selector":[{"type":"TextPositionSelector","start":38,"end":50},{"type":"TextQuoteSelector","exact":"Teixobactin ","prefix":"  |  www.nature.com  |  1Article","suffix":"kills bacteria by a two-pronged "}]}]}
>```
>%%
>*%%PREFIX%%|  www.nature.com  |  1Article%%HIGHLIGHT%% ==Teixobactin== %%POSTFIX%%kills bacteria by a two-pronged*
>%%LINK%%[[#^z1cp2c2f91p|show annotation]]
>%%COMMENT%%
>泰斯巴汀，是美国科学家发现的近30年来第一种新型抗生素，其可以杀死耐甲氧西林金黄色葡萄球菌(MRSA)等多种致命病原体。
>%%TAGS%%
>
^z1cp2c2f91p


>%%
>```annotation-json
>{"created":"2022-08-30T03:44:38.350Z","updated":"2022-08-30T03:44:38.350Z","document":{"title":"Teixobactin kills bacteria by a two-pronged attack on the cell envelope","link":[{"href":"urn:x-pdf:ca6519d0e48a08449bcc274124342edf"},{"href":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf"}],"documentFingerprint":"ca6519d0e48a08449bcc274124342edf"},"uri":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","selector":[{"type":"TextPositionSelector","start":684,"end":1559},{"type":"TextQuoteSelector","exact":". Teixobactin4 represents a new class of antibiotics with a unique chemical scaffold and lack of detectable resistance. Teixobactin targets lipid II, a precursor of peptidoglycan5. Here we unravel the mechanism of teixobactin at the atomic level using a combination of solid-state NMR, microscopy, in vivo assays and molecular dynamics simulations. The unique enduracididine C-terminal headgroup of teixobactin specifically binds to the pyrophosphate-sugar moiety of lipid II, whereas the N terminus coordinates the pyrophosphate of another lipid II molecule. This configuration favours the formation of a β-sheet of teixobactins bound to the target, creating a supramolecular fibrillar structure. Specific binding to the conserved pyrophosphate-sugar moiety accounts for the lack of resistance to teixobactin4.  The supramolecular structure compromises membrane integrity. A","prefix":"mbat antimicrobial resistance1–3","suffix":"tomic force microscopy and molec"}]}]}
>```
>%%
>*%%PREFIX%%mbat antimicrobial resistance1–3%%HIGHLIGHT%% ==. Teixobactin4 represents a new class of antibiotics with a unique chemical scaffold and lack of detectable resistance. Teixobactin targets lipid II, a precursor of peptidoglycan5. Here we unravel the mechanism of teixobactin at the atomic level using a combination of solid-state NMR, microscopy, in vivo assays and molecular dynamics simulations. The unique enduracididine C-terminal headgroup of teixobactin specifically binds to the pyrophosphate-sugar moiety of lipid II, whereas the N terminus coordinates the pyrophosphate of another lipid II molecule. This configuration favours the formation of a β-sheet of teixobactins bound to the target, creating a supramolecular fibrillar structure. Specific binding to the conserved pyrophosphate-sugar moiety accounts for the lack of resistance to teixobactin4.  The supramolecular structure compromises membrane integrity. A== %%POSTFIX%%tomic force microscopy and molec*
>%%LINK%%[[#^g5p2tyjfy6a|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^g5p2tyjfy6a


>%%
>```annotation-json
>{"created":"2022-08-30T03:45:04.123Z","updated":"2022-08-30T03:45:04.123Z","document":{"title":"Teixobactin kills bacteria by a two-pronged attack on the cell envelope","link":[{"href":"urn:x-pdf:ca6519d0e48a08449bcc274124342edf"},{"href":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf"}],"documentFingerprint":"ca6519d0e48a08449bcc274124342edf"},"uri":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","selector":[{"type":"TextPositionSelector","start":2388,"end":2647},{"type":"TextQuoteSelector","exact":"A rapid rise in multidrug-resistant bacteria is a major concern for global health6,7. This threat is exacerbated by a drought in the antibiotic pipe-line3,8, with alarmingly few new classes of antibiotics introduced into the clinic over the past three decades","prefix":"ign of improved drug candidates.","suffix":".In 2015, screening of unculture"}]}]}
>```
>%%
>*%%PREFIX%%ign of improved drug candidates.%%HIGHLIGHT%% ==A rapid rise in multidrug-resistant bacteria is a major concern for global health6,7. This threat is exacerbated by a drought in the antibiotic pipe-line3,8, with alarmingly few new classes of antibiotics introduced into the clinic over the past three decades== %%POSTFIX%%.In 2015, screening of unculture*
>%%LINK%%[[#^wxv6f95qhys|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^wxv6f95qhys


>%%
>```annotation-json
>{"created":"2022-08-30T03:45:29.864Z","updated":"2022-08-30T03:45:29.864Z","document":{"title":"Teixobactin kills bacteria by a two-pronged attack on the cell envelope","link":[{"href":"urn:x-pdf:ca6519d0e48a08449bcc274124342edf"},{"href":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf"}],"documentFingerprint":"ca6519d0e48a08449bcc274124342edf"},"uri":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220808/s41586-022-05019-y.pdf","selector":[{"type":"TextPositionSelector","start":2733,"end":3241},{"type":"TextQuoteSelector","exact":"a novel antibiotic with broad activity against multidrug- resistant Gram-positive pathogens such as methicillin-resistant Staphy-lococcus aureus, Streptococcus pneumoniae and vancomycin-resistant Enterococci4.  Studies  in  animal  models  of  infection  suggest  that  teixobactin is a promising drug lead4,9,10. Teixobactin is an undeca-peptide that contains five non-canonical amino acids, including four d-amino acids and the cationic l-allo-enduracididine (End10) local-ized in a C-terminal depsi-cycle ","prefix":"amples unearthed  teixobactin4, ","suffix":"(Fig. 1a and Supplementary Fig. "}]}]}
>```
>%%
>*%%PREFIX%%amples unearthed  teixobactin4,%%HIGHLIGHT%% ==a novel antibiotic with broad activity against multidrug- resistant Gram-positive pathogens such as methicillin-resistant Staphy-lococcus aureus, Streptococcus pneumoniae and vancomycin-resistant Enterococci4.  Studies  in  animal  models  of  infection  suggest  that  teixobactin is a promising drug lead4,9,10. Teixobactin is an undeca-peptide that contains five non-canonical amino acids, including four d-amino acids and the cationic l-allo-enduracididine (End10) local-ized in a C-terminal depsi-cycle== %%POSTFIX%%(Fig. 1a and Supplementary Fig.*
>%%LINK%%[[#^5kbjypp85b|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5kbjypp85b
